Target intelligence / Profile preview

Rhodiola rosea

Molecular classification
Other (Medicinal plant, not a molecular biological target)
01

Overview

Rhodiola rosea is a perennial, fleshy-leaved flowering plant found in cold regions of the world, including arctic areas and mountainous parts of Europe, Asia, and North America[1]. Its rhizome and root have been used in traditional medicine as an adaptogen, claimed to enhance resilience to stress and improve mental and physical performance[2]. Contemporary clinical evidence supports its use for temporary relief of stress-related symptoms like fatigue, exhaustion, and impaired cognitive function[2][4]. While several active constituents (notably rosavin, salidroside, and tyrosol derivatives) are studied for their pharmacologic effects, "Rhodiola rosea" itself is a plant extract or preparation rather than a single defined therapeutic molecular target[2][3]. Key note: There is something incorrect with the concept of "Rhodiola rosea" as a molecular or therapeutic target: it does not refer to a protein, receptor, enzyme, or other conventional druggable target, but to a medicinal plant and its extracts. It should not be mapped as a molecular target for structured drug discovery or therapeutic targeting purposes[2][3].

Other names
Golden rootRoserootArctic root
02

Mechanism of action

Adaptogenic (modulates stress-response systems, may affect serotonin, dopamine, and β-endorphin release or signaling; may decrease levels of stress hormones like corticosterone; not receptor-ligand based) [2]

03

Biological functions

Other (Used as an adaptogen; influences stress response systems, but is not a molecular/biological pathway protein, receptor, or enzyme)
04

Disease associations

Other (Used for "stress," fatigue, depressive symptoms, cardiovascular disease, sometimes sexual dysfunction) [2][4]
05

Safety considerations

Generally well-tolerated in clinical studies; potential concerns include drug-herb interactions, quality control of supplements, and unsubstantiated claims [2][4]
06

Biomarkers

C-reactive protein (CRP)creatinine kinase (CK) (used in clinical trials to assess exercise recovery or stress reduction efficacy, but not specific to Rhodiola rosea as a molecular marker) [2]

Beyond the preview

Go deeper on Rhodiola rosea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhodiola rosea.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call